-
Celldex Therapeutics (NASDAQ:CLDX) Receives Overweight Rating from Cantor Fitzgerald
Source: Buzz FX / 29 Jan 2025 09:31:18 America/Chicago
Celldex Therapeutics (NASDAQ:CLDX) Receives Overweight Rating from Cantor Fitzgerald Written by MarketBeat January 29, 2025 Share Link copied to clipboard. Celldex Therapeutics ( NASDAQ:CLDX - Get Free Report ) 's stock had its "overweight"
Read more...